Quantcast
Channel: Modernpharma.in » Dr Reddy’s
Viewing all articles
Browse latest Browse all 5

Dr. Reddy’s announces the launch of Decitabine for Injection

0
0

Dr. Reddy’s Laboratories announced that it has launched Decitabine for Injection, a therapeutic equivalent generic version of Dacogen® (Decitabine for Injection) in the US market on July 11, 2013, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy’s ANDA for Decitabine for Injection.

The Dacogen® brand has U.S. sales of approximately $260 Million MAT for the most recent twelve months ending in July 2013 according to IMS Health*.

Dr. Reddy’s Decitabine for Injection 50 mg is available as a single dose vial. Dacogen® is a registered trademark used by Eisai Inc. under license from Astex Pharmaceuticals, Inc.

 


Viewing all articles
Browse latest Browse all 5

Latest Images

Trending Articles





Latest Images